Medacta Group SA (MEDGF)
Medacta SA Statistics
Share Statistics
Medacta SA has 19.92M shares outstanding. The number of shares has increased by -0.04% in one year.
| Shares Outstanding | 19.92M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.16% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 6.09M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 22.14 and the forward PE ratio is null. Medacta SA's PEG ratio is 0.41.
| PE Ratio | 22.14 |
| Forward PE | n/a |
| PS Ratio | 2.73 |
| Forward PS | n/a |
| PB Ratio | 4.25 |
| P/FCF Ratio | 658.15 |
| PEG Ratio | 0.41 |
Enterprise Valuation
Medacta SA has an Enterprise Value (EV) of 1.82B.
| EV / Sales | 3.09 |
| EV / EBITDA | 11.36 |
| EV / EBIT | 17.02 |
| EV / FCF | 743.64 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.64.
| Current Ratio | 2.51 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 1.5 |
| Debt / FCF | 98.37 |
| Interest Coverage | 12.09 |
Financial Efficiency
Return on Equity is 19.2% and Return on Invested Capital is 10.87%.
| Return on Equity | 19.2% |
| Return on Assets | 9.2% |
| Return on Invested Capital | 10.87% |
| Revenue Per Employee | $309.69K |
| Profits Per Employee | $38.22K |
| Employee Count | 1,907 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 0.82 |
Taxes
| Income Tax | 14.88M |
| Effective Tax Rate | 16.96% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.19, so Medacta SA's price volatility has been higher than the market average.
| Beta | 1.19 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 83.91 |
| 200-Day Moving Average | 83.91 |
| Relative Strength Index (RSI) | 2.96 |
| Average Volume (20 Days) | 2 |
Income Statement
In the last 12 months, Medacta SA had revenue of 590.58M and earned 72.89M in profits. Earnings per share was 3.66.
| Revenue | 590.58M |
| Gross Profit | 399.44M |
| Operating Income | 90.83M |
| Net Income | 72.89M |
| EBITDA | 160.51M |
| EBIT | 95.28M |
| Earnings Per Share (EPS) | 3.66 |
Balance Sheet
The company has 31.59M in cash and 241.21M in debt, giving a net cash position of -209.62M.
| Cash & Cash Equivalents | 31.59M |
| Total Debt | 241.21M |
| Net Cash | -209.62M |
| Retained Earnings | 346.07M |
| Total Assets | 792.18M |
| Working Capital | 237.83M |
Cash Flow
In the last 12 months, operating cash flow was 107.14M and capital expenditures -104.69M, giving a free cash flow of 2.45M.
| Operating Cash Flow | 107.14M |
| Capital Expenditures | -104.69M |
| Free Cash Flow | 2.45M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 67.64%, with operating and profit margins of 15.38% and 12.34%.
| Gross Margin | 67.64% |
| Operating Margin | 15.38% |
| Pretax Margin | 14.86% |
| Profit Margin | 12.34% |
| EBITDA Margin | 27.18% |
| EBIT Margin | 15.38% |
| FCF Margin | 0.42% |
Dividends & Yields
MEDGF pays an annual dividend of $1.39, which amounts to a dividend yield of 1%.
| Dividend Per Share | $1.39 |
| Dividend Yield | 1% |
| Dividend Growth (YoY) | 52.6% |
| Payout Ratio | 55.13% |
| Earnings Yield | 4.52% |
| FCF Yield | 0.15% |
Analyst Forecast
Currently there are no analyst rating for MEDGF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 5.35 |
| Piotroski F-Score | 5 |